Search Results - "ANTILL, Yoland C"

Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles by Thompson, Ella R, Doyle, Maria A, Ryland, Georgina L, Rowley, Simone M, Choong, David Y H, Tothill, Richard W, Thorne, Heather, Barnes, Daniel R, Li, Jason, Ellul, Jason, Philip, Gayle K, Antill, Yoland C, James, Paul A, Trainer, Alison H, Mitchell, Gillian, Campbell, Ian G

“…Despite intensive efforts using linkage and candidate gene approaches, the genetic etiology for the majority of families with a multi-generational breast…”
Get full text

Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers by ANTILL, Yoland C, MITCHELL, Gillian, JOHNSON, Sandra A, DEVEREUX, Lisa, MILNER, Alvin, DI IULIO, Juliana, LINDEMAN, Geoffrey J, KIRK, Judy, PHILLIPS, Kelly Anne, CAMPBELL, Ian G

“…Purpose: Genomic alterations (including gene hypermethylation) are likely to precede the phenotypic changes associated with breast tumorigenesis. From a…”
Get full text

Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 Mutation by Willems, Amber J, Dawson, Sarah-Jane, Samaratunga, Hema, De Luca, Alessandro, Antill, Yoland C, Hopper, John L, Thorne, Heather J

“…Purpose: Prostate cancer risk is increased for men carrying a pathogenic germline mutation in BRCA2 , and perhaps BRCA1. Our primary aim was to test for loss…”
Get full text

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 Mutation-Positive Families by Duffy, David L., Antill, Yoland C., Stewart, Colin J., Young, Joanne P., Spurdle, Amanda B.

“…There is evidence that tamoxifen treatment of BRCA1 and BRCA2 carriers for prior breast cancer increases risk of endometrioid subtype endometrial cancer (EC),…”
Get full text

Cancer Risks for MLH1 and MSH2 Mutation Carriers by Dowty, James G., Win, Aung K., Buchanan, Daniel D., Lindor, Noralane M., Macrae, Finlay A., Clendenning, Mark, Antill, Yoland C., Thibodeau, Stephen N., Casey, Graham, Gallinger, Steve, Marchand, Loic Le, Newcomb, Polly A., Haile, Robert W., Young, Graeme P., James, Paul A., Giles, Graham G., Gunawardena, Shanaka R., Leggett, Barbara A., Gattas, Michael, Boussioutas, Alex, Ahnen, Dennis J., Baron, John A., Parry, Susan, Goldblatt, Jack, Young, Joanne P., Hopper, John L., Jenkins, Mark A.

“…ABSTRACT We studied 17,576 members of 166 MLH1 and 224 MSH2 mutation‐carrying families from the Colon Cancer Family Registry. Average cumulative risks of…”
Get full text

Therapeutic options for mucinous ovarian carcinoma by Gorringe, Kylie L., Cheasley, Dane, Wakefield, Matthew J., Ryland, Georgina L., Allan, Prue E., Alsop, Kathryn, Amarasinghe, Kaushalya C., Ananda, Sumitra, Bowtell, David D.L., Christie, Michael, Chiew, Yoke-Eng, Churchman, Michael, DeFazio, Anna, Fereday, Sian, Gilks, C. Blake, Gourley, Charlie, Hadley, Alison M., Hendley, Joy, Hunter, Sally M., Kaufmann, Scott H., Kennedy, Catherine J., Köbel, Martin, Le Page, Cecile, Li, Jason, Lupat, Richard, McNally, Orla M., McAlpine, Jessica N., Pyman, Jan, Rowley, Simone M., Salazar, Carolina, Saunders, Hugo, Semple, Timothy, Stephens, Andrew N., Thio, Niko, Torres, Michelle C., Traficante, Nadia, Zethoven, Magnus, Antill, Yoland C., Campbell, Ian G., Scott, Clare L.

“…Mucinous ovarian carcinoma (MOC) is an uncommon ovarian cancer histotype that responds poorly to conventional chemotherapy regimens. Although long overall…”
Get full text

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures by Pittman, Kenneth, Antill, Yoland C, Goldrick, Amanda, Goh, Jeffrey, Boer, Richard H

“…Denosumab, a bone‐modifying agent, reduces the risk of skeletal‐related events in patients with bone metastases from solid tumors and is generally well…”
Get full text

Psychological outcomes and surgical decisions after genetic testing in women newly diagnosed with breast cancer with and without a family history by Meiser, Bettina, Quinn, Veronica F, Mitchell, Gillian, Tucker, Kathy, Watts, Kaaren J, Rahman, Belinda, Peate, Michelle, Saunders, Christobel, Geelhoed, Elizabeth, Gleeson, Margaret, Barlow-Stewart, Kristine, Field, Michael, Harris, Marion, Antill, Yoland C, Susman, Rachel, Bowen, Michael T, Mills, Llew, Kirk, Judy

“…In patients with early breast cancer, personal and tumour characteristics other than family history are increasingly used to prompt genetic testing to guide…”
Get full text

Loss of Heterozygosity Analysis in Ductal Lavage Samples from BRCA1 and BRCA2 Carriers: A Cautionary Tale by ANTILL, Yoland C, MITCHELL, Gillian, JOHNSON, Sandra A, DEVEREUX, Lisa, MILNER, Alvin, PHILLIPS, Kelly-Anne, CAMPBELL, Ian G

“…Background: Loss of heterozygosity (LOH) in breast ductal lavage (DL) fluid has been reported to be a potential biomarker of malignant change. Interpretation…”
Get full text

Streamlined genetic education is effective in preparing women newly diagnosed with breast cancer for decision making about treatment-focused genetic testing: a randomized controlled noninferiority trial by Quinn, Veronica F., Meiser, Bettina, Kirk, Judy, Tucker, Kathy M., Watts, Kaaren J., Rahman, Belinda, Peate, Michelle, Saunders, Christobel, Geelhoed, Elizabeth, Gleeson, Margaret, Barlow-Stewart, Kristine, Field, Michael, Harris, Marion, Antill, Yoland C., Cicciarelli, Linda, Crowe, Karen, Bowen, Michael T., Mitchell, Gillian

“…Increasingly, women newly diagnosed with breast cancer are being offered treatment-focused genetic testing (TFGT). As the demand for TFGT increases,…”
Get full text

Lynch syndrome and cervical cancer by Antill, Yoland C., Dowty, James G., Win, Aung Ko, Thompson, Tina, Walsh, Michael D., Cummings, Margaret C., Gallinger, Steven, Lindor, Noralane M., Le Marchand, Loïc, Hopper, John L., Newcomb, Polly A., Haile, Robert W., Church, James, Tucker, Katherine M., Buchanan, Daniel D., Young, Joanne P., Winship, Ingrid M., Jenkins, Mark A.

“…Carriers of germline mutations in DNA mismatch repair (MMR) genes are at increased risk of several cancers including colorectal and gynecologic cancers (Lynch…”
Get full text

Body Mass Index in Early Adulthood and Endometrial Cancer Risk for Mismatch Repair Gene Mutation Carriers by Win, Aung Ko, Dowty, James G., Antill, Yoland C., English, Dallas R., Baron, John A., Young, Joanne P., Giles, Graham G., Southey, Melissa C., Winship, Ingrid, Lipton, Lara, Parry, Susan, Thibodeau, Stephen N., Haile, Robert W., Gallinger, Steven, Le Marchand, Loïc, Lindor, Noralane M., Newcomb, Polly A., Hopper, John L., Jenkins, Mark A.

“…To investigate the association of body mass index (BMI) in early adulthood and endometrial cancer risk for carriers of a germline mutation in a DNA mismatch…”
Get full text

Cancer Risks for MLH 1 and MSH 2 Mutation Carriers by Dowty, James G., Win, Aung K., Buchanan, Daniel D., Lindor, Noralane M., Macrae, Finlay A., Clendenning, Mark, Antill, Yoland C., Thibodeau, Stephen N., Casey, Graham, Gallinger, Steve, Marchand, Loic Le, Newcomb, Polly A., Haile, Robert W., Young, Graeme P., James, Paul A., Giles, Graham G., Gunawardena, Shanaka R., Leggett, Barbara A., Gattas, Michael, Boussioutas, Alex, Ahnen, Dennis J., Baron, John A., Parry, Susan, Goldblatt, Jack, Young, Joanne P., Hopper, John L., Jenkins, Mark A.

“…We studied 17,576 members of 166 MLH 1 and 224 MSH 2 mutation-carrying families from the Colon Cancer Family Registry. Average cumulative risks of colorectal…”
Get full text

Screening behavior in women at increased familial risk for breast cancer by Antill, Yoland C, Reynolds, John, Young, Mary Anne, Kirk, Judy A, Tucker, Katherine M, Bogtstra, Tarli L, Wong, Shirley S, Dudding, Tracy E, Di Iulio, Juliana L, Phillips, Kelly-Anne

“…This multicenter study examined the adherence of high-risk women to screening recommendations for breast and ovarian cancer following consultation at a…”
Get full text

Nipple aspiration and ductal lavage in women with a germline BRCA1 or BRCA2 mutation by Mitchell, Gillian, Antill, Yoland C, Murray, William, Kirk, Judy, Salisbury, Elizabeth, Lindeman, Geoffrey J, Di Iulio, Juliana, Milner, Alvin D, Devereaux, Lisa, Phillips, Kelly-Anne

“…The aim of this study was to collect serial samples of nipple aspirate (NA) and ductal lavage (DL) fluid from women with germline BRCA1/2 mutations in order to…”
Get full text

Impact of chemotherapy on patients with mismatch repair deficient advanced endometrial carcinomas-a meta-analysis by Tjokrowidjaja, Angelina, Kok, Peey-Sei, Antill, Yoland C, Scott, Clare L, Mileshkin, Linda R, Friedlander, Michael L, Lee, Chee K

“…Chemo-immunotherapy is standard of care for women with recurrent or advanced mismatch repair deficient (dMMR) endometrial carcinomas (EC). However, it is…”
Get full text

Denosumab: Prevention and management of hypocalcemia, osteonecrosis of the jaw and atypical fractures: Denosumab: rare toxicities by Pittman, Kenneth, Antill, Yoland C, Goldrick, Amanda, Goh, Jeffrey, de Boer, Richard H

Get full text